Quality-of-life effects of prostate-specific antigen screening.

After 11 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men who underwent screening for prostate-specific antigen (PSA) levels. However, the extent to which harms to quality of life resulting from overdiagnosis and treatment counterbalance this benefit is uncertain.

Wever, Elisabeth M (author)
Auvinen, Anssi (author)
Hugosson, Jonas,1955 (author)
Ciatto, Stefano (author)
Nelen, Vera (author)
Kwiatkowski, Maciej (author)
Villers, Arnauld (author)
Páez, Alvaro (author)
Moss, Sue M (author)
Zappa, Marco (author)
Tammela, Teuvo L J (author)
Mäkinen, Tuukka (author)
Carlsson, Sigrid,1982Gothenburg University,Göteborgs universitet,Extern,Institutionen för kliniska vetenskaper, Avdelningen för urologi,External,Institute of Clinical Sciences, Department of Urology(Swepub:gu)xcasig (author)
Korfage, Ida J (author)
Essink-Bot, Marie-Louise (author)
Otto, Suzie J (author)
Draisma, Gerrit (author)
Bangma, Chris H (author)
Roobol, Monique J (author)
Schröder, Fritz H (author)
de Koning, Harry J (author)
Göteborgs universitetExtern (creator_code:org_t)

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Urology and Neph ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.